FDA Import Refusal AEK-9449370-5/10003/1 — GLAXOSMITHKLINE
The FDA refused shipment AEK-9449370-5/10003/1 from GLAXOSMITHKLINE (Canada) on Feb 6, 2026. The refused product falls under Drugs and Biologics — LAMOTRIGINE (ANTI-CONVULSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 6, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61MDA38 LAMOTRIGINE (ANTI-CONVULSANT)
- Charges
- 75